Due to immunosuppressive atmosphere in IRLS high-risk patients, we next wonder to know whether there exited a correlation between IRLS and immune checkpoints such as PD-L1, which might trigger the immunosuppressive environment around the tumour and was reported to be predictive biomarkers for immunotherapy in multiple malignancies. This evidence concerns the gene CD274 and neoplasm.